Trial Profile
Pharmacokinetic interactions with venlafaxine or desvenlafaxine extended-release and indinavir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2012
Price :
$35
*
At a glance
- Drugs Desvenlafaxine (Primary) ; Indinavir (Primary) ; Venlafaxine (Primary)
- Indications Depressive disorders; HIV infections
- Focus Pharmacogenomic; Pharmacokinetics
- 24 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 11 Jan 2012 New trial record